Suchergebnisse - (Person:"Rengo, Giuseppe")

PubPharm (7)

1

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management : Might GRK2 Serve as a New Biomarker?

enthalten in: Cells | 2021

von Bencivenga, L. | Palaia, M. | Sepe, I. | +5

2

GRK2 as a therapeutic target for heart failure

enthalten in: Expert opinion on therapeutic targets | 2018

von Cannavo, A. | Komici, K. | Bencivenga, L. | +5

3

microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases

enthalten in: Frontiers in medicine | 2017

von de Lucia, C. | Komici, K. | Borghetti, G. | +8

4

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors : Signaling and Actions in the Cardiovascular System

enthalten in: Frontiers in pharmacology | 2017

von Cannavo, A. | Liccardo, D. | Komici, K. | +9

5

Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure : a meta-analysis

enthalten in: JACC. Heart failure | 2014

von Savarese, G. | Musella, F. | D'Amore, C. | +11

6

Adrenal adrenoceptors in heart failure

enthalten in: Frontiers in physiology | 2014

von de Lucia, C. | Femminella, G. | Gambino, G. | +7

7

Adrenergic nervous system in heart failure : pathophysiology and therapy

enthalten in: Circulation research | 2013

von Lymperopoulos, A. | Rengo, G. | Koch, W.

ErratumIn: Circ Res. 2016 Aug 5;119(4):e38. - PMID 27492843

1
[1]